can tirzepatide cause diabetes vs. Semaglutide: What You Should Know The catcher in the gut:

Discover the safety considerations, potential interactions, and medical guidance for combining GLP-1 medications like Wegovy or Zepbound with hormone replacement therapy during menopause.

Background Tirzepatide is anticipated to play a pivotal role in managing overweight/obesity and/or type 2 diabetes

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, others are continuing and pushing regulatory boundaries.

GLP-1 (17 mg/mL): A dual GLP-1 and GIP receptor agonist that mimics natural gut hormones to enhance insulin sensitivity, regulate appetite, support glycemic control, and promote fat loss

Discover what that means for Ozempic, Wegovy, and overall GLP-1 results.

Semaglutide and Tirzepatide, two medications gaining popularity, offer a promising pathway to weight loss